These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 31204591
1. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Vermaete I, Dujardin K, Stammen F. Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591 [Abstract] [Full Text] [Related]
2. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center. Aguiar Rosa S, Fiarresga A, Galrinho A, Cacela D, Ramos R, de Sousa L, Gonçalves A, Bernardes L, Patrício L, Branco LM, Ferreira RC. Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717 [Abstract] [Full Text] [Related]
3. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre. Wojtarowicz A, Kornacewicz-Jach Z. Cardiol J; 2017 Jul; 24(2):125-130. PubMed ID: 27734458 [Abstract] [Full Text] [Related]
4. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes. Leal S, Galeote G, Jiménez-Valero S, Sánchez-Recalde A, Salinas P, Ruiz AS, Orbe LC, Dominguéz F, Moreno R, López-Sendón JL. Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474 [Abstract] [Full Text] [Related]
8. Gender Disparities in Clinical Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in the Chinese Han Population: A Cohort Study. Wang Y, Zhao HW, Wang CF, Meng QK, Cui CS, Zhang XJ, Zhu Y, Fan CY, Luo DF, Chen BJ, Luan B, Hou AJ. Heart Lung Circ; 2020 Dec 01; 29(12):1856-1864. PubMed ID: 32611501 [Abstract] [Full Text] [Related]
9. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy. Fortunato de Cano S, Nicolas Cano M, de Ribamar Costa J, Alves Pinheiro J, Bellio de Mattos Barretto R, Costa de Souza Le Bihan D, Abizaid A, Sousa A, Eduardo Sousa J. Catheter Cardiovasc Interv; 2016 Nov 15; 88(6):953-960. PubMed ID: 27143093 [Abstract] [Full Text] [Related]
11. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation. Cooper RM, Shahzad A, Hasleton J, Digiovanni J, Hall MC, Todd DM, Modi S, Stables RH. Europace; 2016 Jan 15; 18(1):113-20. PubMed ID: 26541709 [Abstract] [Full Text] [Related]
12. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Almasood A, Garceau P, Woo A, Rakowski H, Schwartz L, Overgaard CB. JACC Cardiovasc Interv; 2011 Sep 15; 4(9):1030-4. PubMed ID: 21939945 [Abstract] [Full Text] [Related]
13. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy. Shelke AB, Menon R, Kapadiya A, Yalagudri S, Saggu D, Nair S, Narasimhan C. Indian Heart J; 2016 Sep 15; 68(5):618-623. PubMed ID: 27773399 [Abstract] [Full Text] [Related]